Back to Search
PETER JASINSKI, PHARMD
PHARMD
Pharmacist
NPI: 1457640070Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
26526(MA)
Research & Publications (6)
Novel Ras pathway inhibitor induces apoptosis and growth inhibition of K-ras-mutated cancer cells in vitro and in vivo.
PMID 19010291·Transl Res·2008
7-preclinical
Enzastaurin renders MCF-7 breast cancer cells sensitive to radiation through reversal of radiation-induced activation of protein kinase C.
PMID 18448327·Eur J Cancer·2008
8-other
A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines.
PMID 17957339·Invest New Drugs·2008
7-preclinical
Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone.
PMID 18723339·Eur J Cancer·2008
7-preclinical
Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.
PMID 17805485·Invest New Drugs·2008
7-preclinical
Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy.
PMID 17653078·Br J Cancer·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7 E SILVER ST
WESTFIELD, MA 01085 - Phone
- (413) 568-5116
Quick Facts
- NPI
- 1457640070
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile